Moderna CEO Highlights Challenges Due to FDA Uncertainty

Moderna's CEO has expressed concerns over the challenges posed by the uncertainty surrounding the U.S. Food and Drug Administration (FDA). According to Jin10, the CEO emphasized that this uncertainty is creating significant hurdles for the company. The statement reflects ongoing issues within the pharmaceutical industry as companies navigate regulatory landscapes. The CEO's remarks underscore the importance of clear regulatory guidance to facilitate innovation and development in the sector.